Tech Company Financing Transactions

Talima Therapeutics Funding Round

Latterell Venture Partners, U.S. Venture Partners and De Novo Ventures participated in a $19 million Series B funding round for Talima Therapeutics. The round was announced by the company on 5/29/2007.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

75 Shoreway Rd C
San Carlos, CA 94070
USA

Phone

650 331 7246

Website

www.talima.com

Email Address

[email protected]

Overview

Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy we seek to present innovative solutions that overcome drug delivery barriers.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Martin Babler

        

Chief Financial Officer

Paul Denton

        

VP - R & D

Corinne Bright

        

Browse more venture capital transactions:

Prev: 5/29/2007: TravelMuse venture capital transaction
Next: 5/29/2007: Xoomsys venture capital transaction

Share this article

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary